Novel Synthesis of C-Methylated Phytocannabinoids Bearing Anti-inflammatory Properties
Yarden Lavi, Natalya M. Kogan, Louise M. Topping, Caojie Liu, Fiona E. McCann, Richard Williams, Aviva Breuer, Zhanna Yekhtin, Aviva Ezra, Ruth Gallily, Marc Feldmann, Raphael Mechoulam
Abstract
High Resolution Image Download MS PowerPoint Slide There is growing interest in non-psychoactive phytocannabinoids, namely cannabidiol (CBD), cannabigerol (CBG), and cannabichromene, as potential leads for novel therapeutic agents. In this study, we report on the development of new derivatives in which we methylated either position 4 of olivetol or the phenolic positions of olivetol, or both. We introduce a refinement on previously reported chemical procedures for phytocannabinoid derivatization as well as the biological evaluation of all derivatives in anti-inflammatory in vivo models. Compounds such as the CBD derivative, 2 and the CBG derivative, 11, significantly reduced cytokine levels when compared to their parent compounds. Moreover, both of these derivatives proved to be as potent as dexamethasone for the inhibition of IL-1β. We believe that these new derivatives, as described herein, can be further developed as novel drug candidates for inflammatory conditions.